Science Explorer Back to mapMap
Researcher · Sarah Cannon · United States

James D. Peyton

James D. Peyton publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology and Gastric Cancer Management and Outcomes.

OpenAlex
World rank
#3,445,769
of 7,710,434 ranked researchers
Rank in United States
#966,703
of 1,627,098
Works
30
Citations
466
Citations per work
15.5
h-index
11
i10-index 12Top 54% in Oncology

What does James D. Peyton research?

James D. Peyton's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (19%), Pharmacology, Toxicology and Pharmaceutics (2%).

Life Sciences21%Health Sciences63%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1963.0%
    1. Biochemistry, Genetics and Molecular Biology619.1%
    2. Pharmacology, Toxicology and Pharmaceutics12.2%
  1. Everything else515.7%
  1. 1Oncology27% of their works
  2. 2Pulmonary and Respiratory Medicine24% of their works
  3. 3Molecular Biology19% of their works
  4. 4Surgery9% of their works
  5. 5Hepatology3% of their works
  6. 6Toxicology2% of their works

Research topics

Which keywords describe James D. Peyton's research?

The keywords of their largest research topics: Chemotherapy, EGFR Mutations, Targeted Therapy, Adjuvant Therapy, Endoscopic Resection, Clinical Practice Guidelines, Chemotherapy-Induced Peripheral Neuropathy and Gastric Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Chemotherapy133 topics
  2. EGFR Mutations101 topic
  3. Targeted Therapy101 topic
  4. Adjuvant Therapy92 topics
  5. Endoscopic Resection92 topics
  6. Clinical Practice Guidelines82 topics
  7. Chemotherapy-Induced Peripheral Neuropathy51 topic
  8. Gastric Cancer51 topic
  9. Molecular Characterization51 topic
  10. Taxanes51 topic
  11. CT Screening41 topic
  12. Cetuximab41 topic
  13. Esophageal Carcinoma41 topic
  14. KRAS Mutations41 topic
  15. Lung Cancer41 topic
  16. Preoperative Chemoradiotherapy41 topic
  17. Hepatocellular Carcinoma31 topic
  18. Liver Cancer31 topic
  19. Molecular Chaperones31 topic
  20. Protein Folding31 topic

Where does James D. Peyton work?

James D. Peyton's main affiliation in the publication record is Sarah Cannon, United States.

How many publications and citations does James D. Peyton have?

OpenAlex counts 30 works and 466 citations for James D. Peyton, an h-index of 11, ranking #3,445,769 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about James D. Peyton. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.